21 August 2021>: Clinical Research
Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease – A Prospective Study Between 2016 and 2017 at a Single Center
Zhongliang Dai 1ACDE , Miao Lin 1BDE , Yali Li 1BE , Wenli Gao 1BDE , Ping Wang 1BDE , Juan Lin 1CE , Zhenzhen Wan 2AE* , Yuanxu Jiang 1CE*DOI: 10.12659/MSM.929835
Med Sci Monit 2021; 27:e929835
Table 3 Secondary endpoints.
Variables | Sevoflurane (n=81) | Propofol (n=83) | P |
---|---|---|---|
Delirium, n (%) | 36 (44.4) | 35 (42.2) | 0.797 |
PONV, n (%) | 15 (18.5) | 14 (16.9) | 0.866 |
ICU Length-of-stay (hours) | 13 (16.0) | 14 (16.9) | 0.642 |
In-hospital morbidity and mortality, n (%) | 2 (2.5) | 1 (1.2) | 0.213 |
Length-of-stay in hospital (days) | 8 (9.9) | 9 (10.8) | 0.356 |
PONV – postoperative nausea and vomiting; ICU – Intensive Care Unit. |